John Paulson's investment portfolio showcases a strategic inclination towards pharmaceuticals and resource-based companies. Madrigal Pharmaceuticals Inc, a leader in developing innovative therapies for cardiovascular-metabolic diseases, holds a significant position in Paulson's stocks collection, testifying to his faith in biotech's growth potential. Bausch Health Companies Inc further diversifies his interest in the healthcare sector, with this company being a global provider of diversified pharmaceuticals.
The finance sector is represented through BrightSphere Investment Group Inc, where Paulson sees value in asset management firms. This aligns with a broader investment play on financial services industry dynamics.
Heading into natural resources, Perpetua Resources Corp reflects Paulson's bet on sustainable mining operations, indicating an environmentally conscious yet profitability-focused strategy. Novagold Resources Inc complements this approach with its stake in precious metal exploration—particularly gold—which acts as a hedge against market volatility and inflation.
Paulson's top five investments reveal a balanced mix between high-growth potential pharma and steady-eddy resource sectors, signaling a blended risk appetite to seasoned and novice investors alike.
Jan 18, 2024
Increased shares by 3.7%
Added 3.7% on Jan 18, 2024
Q4 2023
Sold -2.1 Million shares
Sold 100% in Q4 2023
Q4 2023
Increased shares by 121.1%
Added 121.1% in Q4 2023
Q4 2023
Increased shares by 133.5%
Added 133.5% in Q4 2023
Q4 2023
Increased shares by 5.9%
Added 5.9% in Q4 2023
Q3 2023
Sold -3.83 Million shares
Sold 100% in Q3 2023
Q3 2023
Sold -452 Thousand shares
Sold 100% in Q3 2023
Q3 2023
Sold -25 Thousand shares
Sold 100% in Q3 2023
Q3 2023
Sold -50 Thousand shares
Sold 100% in Q3 2023
Q2 2023
Sold -1.65 Million shares
Sold 100% in Q2 2023
Q2 2023
Sold -892 Thousand shares
Sold 100% in Q2 2023
Q1 2023
Sold -2.33 Million shares
Sold 100% in Q1 2023
Q1 2023
Sold -2.81 Million shares
Sold 100% in Q1 2023
Q1 2023
Sold -294 Thousand shares
Sold 100% in Q1 2023
Q1 2023
Sold -20.3 Thousand shares
Sold 100% in Q1 2023
Q4 2022
Sold -265 Thousand shares
Sold 100% in Q4 2022
Q4 2022
Sold -1.2 Million shares
Sold 100% in Q4 2022
Q4 2022
Sold -1.6 Million shares
Sold 100% in Q4 2022
Q4 2022
Sold 24.2% shares
Sold 24.2% in Q4 2022
Q4 2022
Sold 35.9% shares
Sold 35.9% in Q4 2022
Q4 2022
Sold 6.5% shares
Sold 6.5% in Q4 2022
Q4 2022
Sold -300 Thousand shares
Sold 100% in Q4 2022
Q3 2022
Sold -2.5 Million shares
Sold 100% in Q3 2022
Q3 2022
Sold -7.5 Million shares
Sold 100% in Q3 2022
Q3 2022
Sold -350 Thousand shares
Sold 100% in Q3 2022
Q3 2022
Sold -90 Thousand shares
Sold 100% in Q3 2022
Q3 2022
Sold -81 Thousand shares
Sold 100% in Q3 2022
Q3 2022
Sold -7.79 Million shares
Sold 100% in Q3 2022
Q3 2022
Sold 23.7% shares
Sold 23.7% in Q3 2022
Q2 2022
Sold -1 Million shares
Sold 100% in Q2 2022
Easily embed the chart on your blog or website – it will always update automatically!